CinnamtanninD2

CAS No. 97233-47-1

CinnamtanninD2( ——— )

Catalog No. M39777 CAS No. 97233-47-1

Cinnamtannin D2 (compound 13) is a cinnamon tannin isolated from Vaccinium vitis-idaea L.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CinnamtanninD2
  • Note
    Research use only, not for human use.
  • Brief Description
    Cinnamtannin D2 (compound 13) is a cinnamon tannin isolated from Vaccinium vitis-idaea L.
  • Description
    Cinnamtannin D2 (compound 13) is a cinnamon tannin isolated from Vaccinium vitis-idaea L.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    97233-47-1
  • Formula Weight
    1153.01
  • Molecular Formula
    C60H48O24
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Morimoto S, et al. Tannins and Related Compounds. LX.: Isolation and Characterization of Proanthocyanidins with a Doubly-Linked Unit from Vaccinium vitis-idaea LJ. Chemical and pharmaceutical bulletin, 1988, 36(1): 33-38.
molnova catalog
related products
  • ML221

    ML221 is a potent?apelin /APJ?functional antagonist, inhibiting apelin-13-mediated activation of APJ, with?IC50s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, and?EC80?of 10 nM in both assays.

  • NGR peptide Trifluor...

    NGR peptide Trifluoroacetate containing the asparagine-glycine-arginine (NGR) motif is recognized by CD13/aminopeptidase N (APN) receptor isoforms that are selectively overexpressed in tumor neovasculature.

  • CITCO

    CITCO inhibits growth and expansion of brain tumour stem cells (BTSCs) and has an EC50 of 49?nM over pregnane X receptor (PXR), and no activity on other nuclear receptors.